Advertisement

Temozolomide

Thrombocytopenia and neutropenia following off-label use: 5 case reports

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Faivre G, et al. Temozolomide as a Single Agent Maintenance Therapy in Elderly Patients With Primary CNS Lymphoma. Clinical Lymphoma, Myeloma & Leukemia 19: 665-669, No. 10, Oct 2019. Available from: URL: http://doi.org/10.1016/j.clml.2019.05.012

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Temozolomide. Reactions Weekly 1786, 154 (2020). https://doi.org/10.1007/s40278-020-73628-2

    Download citation